ADHD Medication During Pregnancy and Breastfeeding
The choice of whether to stop or continue ADHD medications during breastfeeding and pregnancy is a difficult decision for women suffering from the condition. There aren't enough data regarding how exposure over time may affect a fetus.
A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems such as hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge the need for more high-quality studies.
Risk/Benefit Analysis
Pregnant women who take ADHD medications need to balance the benefits of using them against the risks to the fetus. Doctors don't have the information needed to make unequivocal recommendations, but they can provide information about benefits and risks that can assist pregnant women in making informed decisions.
A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during their early pregnancy did not have a greater risk of fetal malformations, or structural birth defects. The researchers used a large, population-based case-control study to evaluate the incidence of major structural birth defects in babies born to mothers who had taken stimulants during the early stages of pregnancy and those who had not. Pediatric cardiologists, clinical geneticists and other experts reviewed the cases in order to ensure that the classification was accurate and to minimize any bias.
However, the researchers' study had its limitations. The most important issue was that they were unable to distinguish the effects of the medication from the effects of the disorder at hand. medication for adults with add makes it difficult for researchers to determine whether the few associations observed between the groups that were exposed to the use of medications, or if they were confounded by comorbidities. The researchers also did not study long-term outcomes for the offspring.
The study revealed that babies whose mothers had taken ADHD medication during pregnancy had a greater risk of being admitted to the neonatal care unit (NICU), compared to mothers who didn't take any medication during pregnancy or had quit taking the medication prior to or during pregnancy. This increase was due to central nervous system-related disorders, and the higher risk of admission was not found to be influenced by which stimulant medications were used during pregnancy.
Women who were taking stimulant ADHD medication during pregnancy were also at an increased chance of having a caesarean section or having a baby with low Apgar score (less than 7). These increases appear to be independent of the type of medication taken during pregnancy.
Researchers suggest that the minor risks associated with the use ADHD medications in early pregnancies could be offset by the greater benefits for mother and baby from continuing treatment for the woman’s disorder. Physicians should talk to their patients about this issue and as much as possible, assist them improve coping skills which can lessen the effects of her disorder on her daily functioning and her relationships.
Medication Interactions
As more women than ever are being diagnosed with ADHD and treated with medication, the issue of whether to continue or discontinue treatment during pregnancy is a question that more and more doctors face. Most of the time, these decisions are made in the absence of clear and authoritative evidence either way, so physicians have to weigh their experience, the experiences of other doctors, and what research suggests about the subject and their own judgments for each patient.
The issue of potential risks to infants is extremely difficult. The research that has been conducted on this topic is based on observations rather than controlled studies, and many of the findings are contradictory. Additionally, the majority of studies limit their analysis to live births, which may underestimate severe teratogenic effects that cause abortion or termination of the pregnancy. The study that is discussed in the journal club addresses these issues by analyzing data on live and deceased births.
The conclusion The conclusion: While some studies have shown an association between ADHD medications and the risk of certain birth defects, others have found no connection and the majority of studies demonstrate a neutral or slight negative effect. As a result an accurate risk-benefit analysis is required in every instance.
For a lot of women with ADHD, the decision to discontinue medication is difficult if not impossible. In an article recently published in Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of isolation, and family conflict for these patients. Additionally, the loss of medication may affect the ability to complete jobs and drive safely that are crucial aspects of a normal life for many people suffering from ADHD.
She suggests that women who are unsure whether to take the medication or stop due to pregnancy, educate their family members, colleagues, and their friends about the condition, the effects on daily functioning, and the benefits of continuing the current treatment. It will also help a woman feel confident about her decision. Certain medications can be passed through the placenta. If a patient decides not to take her ADHD medication while breastfeeding, it's important to be aware that the drug could be transferred to the infant.
Birth Defects and Risk of
As the use and misuse of ADHD medications to treat the symptoms of attention deficit disorder hyperactivity disorder (ADHD), increases the concern over the potential effects of these drugs on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this subject. Using two massive data sets, researchers were able to examine more than 4.3 million pregnancies to determine whether stimulant medications increased the risk of birth defects. Researchers discovered that although the risk overall is low, the first trimester ADHD exposure to medication was associated with slightly higher risk of specific heart defects like ventriculoseptal defect.
The authors of the study found no link between early use of medication and other congenital abnormalities, like facial clefting, or club foot. The results are consistent with previous studies that have shown an increase, but not significant, in the risk of cardiac malformations among women who began taking ADHD medications prior to the time of pregnancy. This risk increased during the latter stages of pregnancy, when a lot of women began to stop taking their medication.
Women who took ADHD medication in the first trimester of pregnancy were also more likely to experience a caesarean section, a low Apgar score after delivery and a baby who required breathing assistance at birth. The authors of the study were unable to eliminate bias due to selection because they limited the study to women who did not have any other medical conditions that could have contributed to the findings.
Researchers hope their research will provide doctors with information when they meet pregnant women. They advise that while discussing risks and benefits is important, the decision to stop or keep medication should be based on each woman's requirements and the severity of her ADHD symptoms.
The authors caution that, even though stopping the medication is an option to consider, it is not advised due to the high prevalence of depression and mental health issues for women who are pregnant or who have recently given birth. Further, the research suggests that women who decide to stop their medications are more likely to experience a difficult time adapting to life without them following the birth of their baby.
Nursing
It can be overwhelming to become a mother. Women with ADHD may face a lot of challenges when they must manage their symptoms, go to doctor appointments and prepare for the birth of a baby and adjust to new routines. Many women decide to continue taking their ADHD medication during pregnancy.
The majority of stimulant drugs are absorbed through breast milk in small amounts, therefore the risk to the nursing infant is very low. The rate of exposure to medication can vary depending upon the dosage and frequency of administration as well as the time of the day. In addition, individual medications enter the body of the baby differently through the gastrointestinal tract as well as breast milk. The impact of this on a newborn infant is not yet fully understood.
Due to the absence of research, some doctors might be tempted to stop taking stimulant drugs during the pregnancy of a woman. It's a difficult choice for the woman, who must weigh the advantages of taking her medication as well as the risks to the fetus. In the meantime, until more information is available, doctors should ask all pregnant patients about their history of ADHD and whether they are taking or planning to take medication during the perinatal period.
A increasing number of studies have revealed that women can continue taking their ADHD medication during pregnancy and while breastfeeding. In the end, more and more patients are choosing to do so and after consulting with their doctor, they have found that the benefits of continuing their current medication far outweigh any potential risks.
Women with ADHD who are planning to nurse should seek advice from an expert psychiatrist prior to becoming pregnant. They should discuss their medication with their prescriber, and the pros and cons of continuing treatment. This includes non-pharmacological strategies. Psychoeducation should also be offered to help women with ADHD be aware of their symptoms and the underlying disorder, learn about available treatment options and reinforce existing strategies for managing. This should include a multidisciplinary approach with the GP as well as obstetricians, psychiatry and obstetricians. The pregnancy counselling should consist of the discussion of a plan for management for both the mother as well as the child, and monitoring for signs of deterioration, and, if necessary, adjustments to the medication regimen.